Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 644

1.

Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.

Puenpatom RA, Victor TW.

Postgrad Med. 2009 Nov;121(6):9-20. doi: 10.3810/pgm.2009.11.2073.

PMID:
19940413
2.

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group.

Int J Cardiol. 2007 Apr 25;117(2):204-10. Epub 2006 Jul 18.

PMID:
16854482
3.
4.

Sociodemographic risk factors associated with metabolic syndrome in a Mediterranean population.

Buckland G, Salas-Salvadó J, Roure E, Bulló M, Serra-Majem L.

Public Health Nutr. 2008 Dec;11(12):1372-8. doi: 10.1017/S1368980008003492. Epub 2008 Aug 15.

PMID:
18702840
5.

The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.

Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN, Petridis DI, Kapousouzi MI, Satsoglou EA, Mikhailidis DP; MetS-Greece Collaborative Group.

Diabetes Obes Metab. 2005 Jul;7(4):397-405.

PMID:
15955126
6.

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR.

Circulation. 2004 Sep 7;110(10):1245-50. Epub 2004 Aug 23.

7.

Prevalence of metabolic syndrome and factors associated with its components in Chinese adults.

Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A.

Metabolism. 2009 Aug;58(8):1102-8. doi: 10.1016/j.metabol.2009.04.008. Epub 2009 Jun 18.

PMID:
19481771
8.

Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study.

Misra R, Patel T, Kotha P, Raji A, Ganda O, Banerji M, Shah V, Vijay K, Mudaliar S, Iyer D, Balasubramanyam A.

J Diabetes Complications. 2010 May-Jun;24(3):145-53. doi: 10.1016/j.jdiacomp.2009.01.003. Epub 2009 Mar 19.

PMID:
19303333
9.

Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.

Fiuza M, Cortez-Dias N, Martins S, Belo A; VALSIM study investigators.

Rev Port Cardiol. 2008 Dec;27(12):1495-529. English, Portuguese.

10.

[Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62 000 subjects].

Guize L, Thomas F, Pannier B, Bean K, Danchin N, Bénétos A.

Bull Acad Natl Med. 2006 Mar;190(3):685-97; discussion 697-700. French.

PMID:
17140103
11.
12.

High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity.

Papadakis JA, Sidiropoulos PI, Karvounaris SA, Vrentzos GE, Spanakis EK, Ganotakis ES, Kritikos HD, Mikhailidis DP, Boumpas DT.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2):292-8.

PMID:
19473571
13.
14.

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.

Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP.

Curr Med Res Opin. 2010 Mar;26(3):713-9. doi: 10.1185/03007991003590597.

PMID:
20078335
15.

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.

Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW.

Circulation. 2004 Jul 27;110(4):380-5. Epub 2004 Jul 19.

17.

Metabolic syndrome in Italian patients with bipolar disorder.

Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G.

Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):318-23. doi: 10.1016/j.genhosppsych.2008.04.009.

PMID:
18585534
18.

Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.

Liu J, Young TK, Zinman B, Harris SB, Connelly PW, Hanley AJ.

Obesity (Silver Spring). 2006 Mar;14(3):500-8.

19.

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.

Royer M, Castelo-Branco C, Blümel JE, Chedraui PA, Danckers L, Bencosme A, Navarro D, Vallejo S, Espinoza MT, Gómez G, Izaguirre H, Ayala F, Martino M, Ojeda E, Onatra W, Saavedra J, Tserotas K, Pozzo E, Manriquez V, Prada M, Grandia E, Zuniga C, Lange D, Sayegh F; Collaborative Group for Research of the Climacteric in Latin America.

Climacteric. 2007 Apr;10(2):164-70.

PMID:
17453865
20.

Fatty liver and the metabolic syndrome among Shanghai adults.

Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, Dai F, Li F, Chen SY.

J Gastroenterol Hepatol. 2005 Dec;20(12):1825-32.

PMID:
16336439
Items per page

Supplemental Content

Write to the Help Desk